| Nicole Wotus-silvestri, PA-C | |
|
537 Stanton Christiana Rd, Suite 209, Apex Medical Building, Newark, DE 19713-2146 | |
| (302) 633-7550 | |
| (302) 225-3774 |
| Full Name | Nicole Wotus-silvestri |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 20 Years |
| Location | 537 Stanton Christiana Rd, Newark, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508938481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 25MP00136500 (New Jersey) | Secondary |
| 363A00000X | Physician Assistant | C5-0000576 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Weirton Medical Center | Weirton, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wmc Physician Practices Llc | 0244466753 | 87 |
News Archive
A treatment for osteoporosis delivered once a year is as effective as current monthly or weekly osteoporosis regimens at reducing the incidence of bone fractures, according to a new study led by a UCSF research team.
PTC Therapeutics, Inc., the SMA Foundation, and Roche, announced today that their joint research program in Spinal Muscular Atrophy has entered the first stage of clinical development aiming to assess safety and tolerability of an oral compound in healthy volunteers.
Taking opioids prior to reverse shoulder arthroplasty does not hamper patients' chances of having successful outcomes, researchers have found.
Akonni Biosystems, a developer of low-cost, multiplex molecular diagnostic testing systems, today announced that the United States Patent and Trademark Office issued a patent on July 20, 2010 for its method for rapidly purifying nucleic acids. U.S. Patent No. 7,759,112 entitled, "Apparatus, system, and method for purifying nucleic acids" protects the Company's use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification. The patent is owned by Akonni Biosystems.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Wotus-silvestri, PA-C 537 Stanton Christiana Rd, Suite 209, Apex Medical Building, Newark, DE 19713-2146 Ph: (302) 633-7550 | Nicole Wotus-silvestri, PA-C 537 Stanton Christiana Rd, Suite 209, Apex Medical Building, Newark, DE 19713-2146 Ph: (302) 633-7550 |
News Archive
A treatment for osteoporosis delivered once a year is as effective as current monthly or weekly osteoporosis regimens at reducing the incidence of bone fractures, according to a new study led by a UCSF research team.
PTC Therapeutics, Inc., the SMA Foundation, and Roche, announced today that their joint research program in Spinal Muscular Atrophy has entered the first stage of clinical development aiming to assess safety and tolerability of an oral compound in healthy volunteers.
Taking opioids prior to reverse shoulder arthroplasty does not hamper patients' chances of having successful outcomes, researchers have found.
Akonni Biosystems, a developer of low-cost, multiplex molecular diagnostic testing systems, today announced that the United States Patent and Trademark Office issued a patent on July 20, 2010 for its method for rapidly purifying nucleic acids. U.S. Patent No. 7,759,112 entitled, "Apparatus, system, and method for purifying nucleic acids" protects the Company's use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification. The patent is owned by Akonni Biosystems.
› Verified 2 days ago